AUSTIN, Texas, July 18, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that the Federal Circuit Court of Appeals affirmed the Delaware Federal District Court's September 2021 decision that all three CareDx...


Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch